High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue - Effects on Functioning, Wellbeing and Inflammatory Biological Markers

CompletedNot a drug-phase studyMS (type not specified)NCT04562376

What it found

No results found

We found no results in the registry or in papers.

This trial finished 5 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • High-intensity resistance training

Compared with

  • Low frequency of high-intensity resistance training

What it measured

Main measures

  • Fatigue Scale for Motor and Cognitive Functions

    Directly after the intervention (ie change from assessments at baseline to follow-up after the 12 week intervention)

    Thinking and memoryFatigue

Other measures (7)

  • Fatigue Severity Scale

    Directly after intervention

    Fatigue
  • Hospital Anxiety and Depression Scale

    Directly after the intervention

    Mood and sleep
  • Occupational Gaps Questionnaire

    Directly after the intervention

  • Multiple Sclerosis Impact Scale-29

    Directly after the intervention

    Quality of life (reported by participants)
  • Euroqool five dimension five level

    Directly after the intervention

    Quality of life (reported by participants)
  • Euroqool visual analogue scale

    Directly after the intervention

    Quality of life (reported by participants)
  • Multiplex proteomic immunoassay and enzyme-linked immunosorbent assay

    Directly after the intervention

    Immune response

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Adults older than 18 years with the diagnosis MS according to the revised McDonald Criteria, having fatigue (i.e. ≥ 53 FSMC sum score), able to understand and communicate in Swedish, and not practicing high-intensity training within 6 months prior to the trial.

Exclusion criteria

* Other conditions or diagnoses judged to potentially interfere with the trial.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Fatigue is one of the most frequently reported and disabling impairments in multiple sclerosis (MS) and is associated with activity limitations, participation restrictions and reduced health-related quality of life (HRQL).MS fatigue is thought to be related to the disease itself, where increased levels of inflammatory biological markers (cytokines) are contributing. Resistance training may have an anti-inflammatory effect where a higher intensity is thought to have a more profound effect. Moderate-intensity resistance training is well tolerated in people with MS (PwMS) and can reduce self-reported fatigue. There is, however, a lack of high-quality studies including only fatigued PwMS when evaluating exercise regimes. Furthermore, the optimal dose (i.e. the combination of duration, frequency and intensity) is not known. Our hypothesis is that high-intensity resistance training will have positive effects in fatigued PwMS on functioning (fatigue, mood, activities and participation) and wellbeing/HRQL; and a positive immunomodulatory effect measured by inflammatory biological markers in blood. Further, that high-intensity resistance training twice a week will be superior to once a week

Loading reviews and guidelines…

History

    1. Started

      Aug 2020

    2. Main results due

      Jun 2021

    3. Finished

      Jun 2022

    Assembled by software from public sources.